EVERSANA CONSULTING Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • EVERSANA CONSULTING's estimated annual revenue is currently $23.9M per year.(i)
  • EVERSANA CONSULTING's estimated revenue per employee is $201,000

Employee Data

  • EVERSANA CONSULTING has 119 Employees.(i)
  • EVERSANA CONSULTING grew their employee count by 8% last year.

EVERSANA CONSULTING's People

NameTitleEmail/Phone
1
Manager, Business OperationsReveal Email/Phone
2
Associate PrincipalReveal Email/Phone
3
Senior ConsultantReveal Email/Phone
4
ConsultantReveal Email/Phone
5
Associate PrincipalReveal Email/Phone
6
Associate PrincipalReveal Email/Phone
7
Senior PrincipalReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$6.6M33-8%N/AN/A
#8
$13.5M67-3%N/AN/A
#9
$186.3M92719%N/AN/A
#10
$4.4M22-4%N/AN/A
Add Company

What Is EVERSANA CONSULTING?

EVERSANA CONSULTING delivers global consulting services to address challenges across the product lifecycle in the pharmaceutical and biotechnology industries. Our team of seasoned, best-in-class consultants specialize in regulatory and compliance, management consulting, and revenue and finance solutions.

keywords:N/A

N/A

Total Funding

119

Number of Employees

$23.9M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EVERSANA CONSULTING News

2022-04-17 - Thread acquires CureClick to improve trial awareness, access

Decentralised clinical trial (DCT) technology and consulting service ... Thread and life sciences commercial services company Eversana...

2022-02-22 - EVERSANA™ MANAGEMENT CONSULTING Named a Best ...

EVERSANA™ is the leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$32.1M1193%N/A
#2
$21.4M11920%N/A
#3
$23.9M11913%$35M
#4
$21.4M11917%N/A
#5
$11.9M1190%N/A